Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DEPO-TESTADIOL

ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE

Standard Dose
2MG/ML;50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DEPO-TESTADIOL is listed in Drugs@FDA under application 017968 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE Form and strength INJECTABLE;INJECTION - 2MG/ML;50MG/ML Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 2002-05-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEPO-TESTADIOL is listed in Drugs@FDA under application 017968 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE Form and strength INJECTABLE;INJECTION - 2MG/ML;50MG/ML Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 2002-05-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.